Tourmaline Bio, Inc. (TRML)
Oct 28, 2025 - TRML was delisted (reason: acquired by NVS)
47.98
0.00 (0.00%)
Inactive · Last trade price on Oct 27, 2025

Tourmaline Bio Stock Forecast

Stock Price Forecast

The 12 analysts with 12-month price forecasts for Tourmaline Bio stock had an average target of $49.05, with a low estimate of $47.5 and a high estimate of $58.

Price Target: $49.05 (+2.23%)
Analyst Consensus: Hold

Price Target

TargetLowAverageMedianHigh
Price$47.5$49.05n/a$58
Change-1.00%+2.23%n/a+20.88%

Analyst Ratings

The average analyst rating for Tourmaline Bio stock from 12 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.

Recommendation Trends

No data available
RatingOct 2026
Strong Buyn/a
Buyn/a
Holdn/a
Selln/a
Strong Selln/a
Totaln/a

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.83
from -2.89
EPS Next Year
-4.17
from -3.83
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
------10.20M
EPS
-0.08-22.46-8.87-2.89-3.83-4.17-4.64
No. Analysts
----1098

Revenue Forecast

Revenue20252026202720282029
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth20252026202720282029
High--
Avg--
Low--

EPS Forecast

EPS20252026202720282029
High-3.78-3.56
Avg-3.83-4.17
Low-4.01-4.55

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--